T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Intel
INTC
|
$1.59B |
| 2 |
Dollar General
DG
|
$1.53B |
| 3 |
Charles Schwab
SCHW
|
$1.19B |
| 4 |
Uber
UBER
|
$971M |
| 5 |
Nike
NKE
|
$868M |
Top Sells
| 1 |
Microsoft
MSFT
|
$2.83B |
| 2 |
Amazon
AMZN
|
$2.33B |
| 3 |
NVIDIA
NVDA
|
$1.75B |
| 4 |
Humana
HUM
|
$1.46B |
| 5 |
Alphabet (Google) Class C
GOOG
|
$1.38B |
Sector Composition
| 1 | Technology | 31.18% |
| 2 | Healthcare | 15.82% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.8% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Nucor
NUE
$34.1B
| $366M | 0.05% |
2,102,912
+28,290
| +1% | +$4.92M |
|
302
Boston Scientific
BSX
$156B
| $364M | 0.05% |
6,303,756
+516,386
| +9% | +$29.9M |
|
303
Vulcan Materials
VMC
$38.5B
| $364M | 0.05% |
1,605,175
-51,944
| -3% | -$11.8M |
|
304
Bristol-Myers Squibb
BMY
$96B
| $364M | 0.05% |
7,086,056
+401,783
| +6% | +$20.6M |
|
305
Quest Diagnostics
DGX
$20.3B
| $359M | 0.05% |
2,604,158
+396,447
| +18% | +$54.7M |
|
306
Loews
L
$20.1B
| $359M | 0.05% |
5,158,505
-253,928
| -5% | -$17.7M |
|
307
RenaissanceRe
RNR
$11.4B
| $358M | 0.05% |
1,828,988
-288,887
| -14% | -$56.6M |
|
308
Textron
TXT
$14.3B
| $358M | 0.05% |
4,451,717
-32,355
| -0.7% | -$2.6M |
|
309
Veralto
VLTO
$26.4B
| $356M | 0.05% |
4,326,836
+4,161,115
| +2,511% | +$342M |
|
310
Steris
STE
$24.1B
| $356M | 0.05% |
1,618,014
+85,305
| +6% | +$18.8M |
|
311
Vale
VALE
$43.9B
| $353M | 0.05% |
22,286,695
+21,526,055
| +2,830% | +$341M |
|
312
Popular Inc
BPOP
$8.49B
| $352M | 0.05% |
4,289,731
-356,035
| -8% | -$29.2M |
|
313
Confluent
CFLT
$6.85B
| $351M | 0.05% |
14,994,745
+3,870,881
| +35% | +$90.6M |
|
314
Microchip Technology
MCHP
$35.1B
| $348M | 0.05% |
3,853,717
-193,185
| -5% | -$17.4M |
|
315
RPM International
RPM
$16.1B
| $345M | 0.05% |
3,088,606
-199,066
| -6% | -$22.2M |
|
|
ONC
316
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $344M | 0.05% |
1,908,189
+158,624
| +9% | +$28.6M |
|
317
Nu Holdings
NU
$71.5B
| $343M | 0.05% |
41,224,713
-13,720,599
| -25% | -$114M |
|
318
Charles River Laboratories
CRL
$8.04B
| $341M | 0.05% |
1,443,175
-237,498
| -14% | -$56.1M |
|
|
SUM
319
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $339M | 0.05% |
8,814,270
+3,339,736
| +61% | +$128M |
|
320
Insmed
INSM
$28.8B
| $334M | 0.04% |
10,763,771
+356,555
| +3% | +$11M |
|
321
Caterpillar
CAT
$196B
| $333M | 0.04% |
1,124,920
-654,583
| -37% | -$194M |
|
322
Ralph Lauren
RL
$18B
| $326M | 0.04% |
2,263,164
-55,584
| -2% | -$8.02M |
|
323
Burlington
BURL
$18.3B
| $325M | 0.04% |
1,672,007
+125,082
| +8% | +$24.3M |
|
324
Novanta
NOVT
$4.19B
| $325M | 0.04% |
1,927,689
+849,703
| +79% | +$143M |
|
325
Zscaler
ZS
$43.1B
| $321M | 0.04% |
1,450,145
+5,796
| +0.4% | +$1.28M |
|